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Abstract 
Objectives: Medication non‑adherence is a significant problem in treatment of severe mental disorders and is 
associated with poor clinical outcomes and increased demand on services. Task‑shifting interventions incorporating 
mobile health may improve adherence in mental health service users in low‑ and middle‑income countries. Seventy‑
seven participants were recruited from a psychiatric hospital in Cape Town, with 42 randomized to receive the 
intervention and 35 to treatment as usual. Intervention pairs underwent treatment‑partner contracting and psych‑
oeducation, and received monthly text message reminders of clinic appointments. Primary outcomes were interven‑
tion acceptability and feasibility. Secondary outcome for efficacy were adherence to clinic visit; relapse; quality of life; 
symptomatic relief and medication adherence.
Results: Treatment partner and psychoeducation components were acceptable and feasible. The text message com‑
ponent was acceptable but not feasible in its current form. Efficacy outcomes favoured the intervention but did not 
reach statistical significance. A treatment‑partner intervention is acceptable and feasible in a low‑ and middle‑income 
setting. Work is needed to ensure that additional components of such interventions are tailored to the local context. 
Appropriately powered efficacy studies are needed.
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Introduction
Poor medication adherence is a major problem in the 
treatment of severe mental disorders and is associated 
with poor clinical outcomes and increased demand on 
services [1–3]. Thus, there is significant interest in devel-
oping interventions to improve medication adherence in 
this group [4, 5].
Mental health services are under-resourced globally, 
with low- and middle-income countries (LMIC) facing 
a particular challenge [6]. One approach that seeks to 
address the shortfall is task-shifting, which refers to the 
delivery of evidence-based interventions by non-special-
ist workers [7–9]. Treatment partner interventions may 
represent a useful task-shifting approach in adherence-
promotion for mental health service users (MHSU). A 
MHSU is an individual accessing care, treatment and 
rehabilitation services via a health establishment for the 
purpose of enhancing his or her mental health status [10].
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Telephone prompts have shown promise in encour-
aging treatment adherence and clinic attendance [4, 
11]. Mobile health (m-health), defined as medical and 
public health practice supported by mobile devices, is 
gaining popularity worldwide [12, 13]. While m-health 
approaches require further investigation to establish 
efficacy, they have been adopted in maternal and child 
health, and chronic diseases [12, 14, 15]. This technology 
has not been widely used in adherence-focused mental 
health interventions in LMIC.
Approaches to adherence-support have emphasized the 
importance of health literacy, problem-solving, and social 
support, as well as the potential of telephone prompts [4, 
5]. It is however unclear whether an approach incorpo-
rating these components is feasible in a LMIC setting.
Our two-arm non-blinded prospective pilot rand-
omized controlled trial evaluated the acceptability and 
feasibility of a treatment partner and text message inter-




We recruited over 2  years from Valkenberg hospital 
(VBH), which offers public psychiatric services in Cape 
Town, and at 15 psychiatry clinics in the hospital’s catch-
ment area. VBH has 116 male, and 84 female beds with 
majority of patients having a diagnosis of severe mental 
illness, constituting a significant service and disability 
burden [16]. The psychiatry clinics providing post-dis-
charge care in the VBH catchment area are run by mental 
health nurses.
We screened clinical folders of MHSU in the pre-dis-
charge wards at VBH. We included MHSU diagnosed 
with schizophrenia spectrum disorder, substance induced 
psychotic disorder, and bipolar mood disorder type I. 
We approached eligible MHSU and obtained informed 
consent from those willing to participate after being 
informed about the study. Exclusion criteria included: (a) 
a diagnosis of psychotic disorder due to a general medi-
cal condition, dementia, moderate to severe intellectual 
disability; or (b) suicidality; or (c) an inability to give 
informed consent.
Participants were randomized to either interven-
tion or treatment as usual (TAU), using a randomiza-
tion sequence generated by an external statistician. We 
ensured allocation concealment by using opaque, sealed 
sequentially numbered envelopes.
Intervention participants nominated a treatment 
partner from within their social support network. An 
appointment was set at a date preceding the participant’s 
discharge from VBH for intervention procedures to be 
initiated.
Routine care and study activities are described in 
Table  1. The intervention incorporated TAU with the 
addition of (1) a treatment partner contracting and psy-
choeducation session and (2) text message reminders 
of clinic appointments. Intervention development was 
informed by focus group and in-depth interview work 
(published elsewhere), where we found there was a need 
for caregiving relationships to be negotiated to protect he 
MHSU’s autonomy [17].
The treatment partner contracting and psychoeduca-
tion session was conducted with the intervention pair at 
VBH on the agreed-upon date. Psychoeducation focused 
on the participant’s diagnosis and was based on the 
national institute for mental health and the VBH psych-
oeducation guidelines, with input from specialist psychi-
atrists at VBH [18]. Psychoeducation addressed mental 
health literacy needs uncovered during our formative 
work and included psychiatry clinic follow-up processes. 
An individualized participant/treatment partner relation-
ship was negotiated and agreed upon, detailing a com-
munication and adherence-support approach.
Upon discharge, participant information was loaded 
onto a text message system using one enrolment hand-
set. Fifteen fieldworker handsets were programmed for 
use by the nurses. Once enrolled, the fieldworker hand-
sets were remotely populated with the relevant partici-
pant information. Once discharged, the intervention pair 
received a text message, indicating the appointment clinic 
and date. Another text message was sent 1  week before 
the appointment. TAU participants received no text mes-
sages. When participants arrived at the clinic the nurse 
used the handsets to mark the participant’s attendance, 
and to schedule a follow-up appointment on the system, 
which then sent similar notifications to those sent upon 
discharge. Nurses scheduled 2 follow-up appointments in 
total.
Assessment measures
Participants underwent a structured clinical interview for 
diagnosis of axis-I disorders (SCID-I) to confirm diagno-
sis, which included a global assessment of function scale 
(GAF) and clinical global impressions scale (CGI). We 
administered the positive and negative syndrome scale 
(PANSS) to measure severity of psychotic symptoms. 
These scales have been widely used locally in genet-
ics and treatment studies [3, 19–22]. The Camberwell 
assessment of needs scale (CAN) was used to measure 
met and unmet needs [23]. The EUROQOL was used to 
measure functional level, and the medication adherence 
rating scale (MARS) was used as a measure of medica-
tion adherence [24, 25].
We used the text message system to track interven-
tion group attendance at first clinic visit. The attendance 
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of both groups was additionally captured retrospec-
tively from the attendance registers at the clinics. All 
participants needed to return for a follow-up study visit 
3-months from enrolment. The MARS, PANSS, CAN 
and EUROQUOL were re-administered at this visit, fol-
lowing which a semi-structured interview was conducted 
with all participants. Participants were asked about their 
diagnosis and treatment, their adherence behaviour and 
about their clinic experience. TAU group were asked 
about the standard pre-discharge psychoeducation, and 
the intervention group about the psychoeducation ses-
sion. Caregivers and treatment partners provided feed-
back about the experience of their adherence support 
role, and on participants’ adherence behaviour. Inter-
vention pairs provided feedback on the components of 
the intervention. These audio-recorded interviews were 
conducted in the language of respondents’ choice, in the 
presence of a translator and transcribed before undergo-
ing thematic analysis.
At 9 months, readmissions were noted via Clinicom, a 
secure online platform used to track health service users 
accessing public health services in Cape Town, which 
maintains detailed notes regarding assessments, admis-
sions, and treatment (see Additional file 1).
We expected that the intervention would be accept-
able and feasible, and result in increased first clinic vis-
its and reduced 9-month readmissions. We expected an 
improvement in medication adherence and quality of life, 
a reduction of needs and symptomatic improvement.
Statistical analysis
Primary outcomes were intervention acceptability and 
feasibility. Efficacy outcomes, which were secondary, 
were adherence to first clinic visit; relapse, defined as 
readmission to hospital; medication adherence; qual-
ity of life and symptomatic relief. Data for clinic visits 
and readmission were complete. The efficacy outcomes 
had incomplete outcome data as only 34 participants 
attended the study visit at 3 months. We report all effect 
measures as risk ratios or mean differences with their 
corresponding 95% confidence intervals. A two-tailed 
significance level of 5% was used throughout and analy-
ses were conducted using Stata version 13.
Results
The participant flow diagram is available as an additional 
figure (see Additional file 2). Seventy-seven participants 
were randomized, 42 to the intervention and 35 to TAU. 
Efficacy outcomes were analyzed at the end of the 2-year 
recruitment period (n = 77). With the significant partici-
pant attrition at 3-month study follow up, we calculated 
that a sample size of 520 would be required to demon-
strate a moderate effect.
Sample demographic characteristics are presented in 
Table 2.
Treatment partners included family members, partners 
and friends. At 3-month review, intervention participants 
understood their diagnosis better than TAU participants. 
Understanding of medication regimen and reported 
treatment adherence were similarly low in both groups. 
The psychoeducation session was seen to be superior 
to standard pre-discharge psychoeducation. Treatment 
partners showed a better knowledge of diagnosis. Inter-
vention pairs felt that a psychoeducation follow-up would 
be valuable in the long-term to reinforce knowledge.
Some participants (41.2%) did not receive the text mes-
sages, either due to changed cellphone numbers or due to 
misplacement or theft of cellphones. Those who received 
the text messages all found them helpful. The nurses 
found the refreshing of handsets burdensome and chal-
lenging in spite of reinforcement training. Three of the 
fieldworker handsets were lost through theft.
All participants found the clinic easy to access and nav-
igate. More treatment partners than caregivers found the 
clinic helpful in supporting adherence. The experiences 
of being a treatment partner and a caregiver were similar, 
with half in each group reporting a positive experience 
and the other half experiencing it as challenging [26].
The intervention was acceptable. The psychoeduca-
tion and the treatment partner components were feasible 
while there were significant challenges with the text mes-
sage system.
Efficacy outcome data is represented in Table  3. TAU 
participants were more likely to miss their first clinic 
visit and to relapse in the 9 months following discharge. 
At 3  month review, TAU participants were more likely 
to show worsening PANNS scores, while GAF scores 
showed better improvement amongst intervention par-
ticipants. CGI scores suggested a symptom improvement 
for the intervention group while the GAF scores of both 
groups suggested general improvement in functioning. 
There was a trend towards an increase in unmet needs 
in the TAU group vs a decline in the intervention group, 
while met needs were seen to increase in both groups.
Discussion
We found that (1) The treatment-partner and psychoedu-
cation components were acceptable and feasible; (2) The 
text message component was acceptable but not feasible 
in its current form; and (3) Efficacy outcomes favoured 
the intervention but did not reach statistical significance.
The acceptability and feasibility of this intervention is 
consistent with prior literature [8]. Our approach was 
in line with previous caregiver focused interventions, 
which have targeted mental health literacy on the experi-
ence of caregiving. Family psychoeducation interventions 
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have reduced relapse in people living with severe men-
tal illness, while helping to meet caregiver needs [27, 
28]. While it has been more difficult to change coping 
styles and reduce caregiver burden, short term interven-
tions have improved caregivers’ knowledge and attitudes 
towards MHSU and mental illness [29, 30].
Table 2 Baseline variables
a Baseline variables with missing data included: marital status: n = 6, ethnicity: n = 6, HLOE: n = 9, employment = 9, PANSS: n = 2, CGI: n = 7, GAF score: n = 14, CAN: 







Statistic (df) p value
Mean (SD) Mean (SD) Mean (SD)
Participant characteristics
 Age 35.5 (10.2) 35.3 10.9 35.8 9.5 t = − 0.35 (75) 0.726
N (%) N (%) N (%)
 Sex χ2 = 1.03 (1) 0.311
  Male 55 71.4 28 66.6 27 77.1
  Female 22 28.6 14 33.3 8 22.9
 Ethnicity χ2 = 0.51 (2) 0.774
  Coloured 47 66.2 26 66.7 21 65.6
  Black 18 25.3 9 23.1 9 23.1
  Other 6 8.5 4 10.3 2 6.3
 Marital status χ2 = 0.29 (1) 0.591
  Never married 51 71.8 27 69.2 24 75.0
  Ever married 20 28.2 12 30.8 8 25.0
 Highest level of education χ2 = 0.15 (2) 0.930
  Grade 7 or less 12 17.7 6 16.7 6 18.7
  Grades 8 to 11 42 61.8 22 61.1 20 62.5
  Grade 12 14 20.6 8 22.2 6 18.8
 6 month employment χ2 = 0.31 (1) 0.579
  Unemployed 47 69.1 28 71.8 19 65.5
  Employed 21 30.9 11 28.2 10 34.5
 Diagnosis 0.604
  Schizophrenia Spectrum 62 80.5 32 76.2 30 85.7
  Bipolar mood disorder 11 14.3 7 16.7 4 11.4
  Substance induced psychotic disorder 4 5.2 3 7.1 1 2.9
 Substance use χ2 = 0.18 (1) 0.671
  Lifetime substance use disorder 31 40,3 16 38.1 15 42.9
 Antipsychotic
  First generation 50 64.9 26 61.9 24 68.6 χ2 = 0.37 (1) 0.542
  Second generation 19 24.7 12 28.6 7 20.0 χ2 = 0.75 (1) 0.385
  Long acting injectable 22 28.6 10 23.8 12 34.29 χ2 = 1.03 (1) 0.311
Baseline measures
 PANSS subscales
  Positive 15.4 6.5 15.6 6.9 15.2 6.2 t = 0.06 (73) 0.951
  Negative 14.4 4.7 13.8 4.8 15.1 4.5 t = − 1.47 (73) 0.015
  General 26.8 7.5 26.5 7.9 27.1 7.2 t = − 0.44 (73) 0.663
  Total 56.6 15.9 55.9 17.1 57.4 14.5 t = − 0.42 (73) 0.676
 CGI 3.5 1 3.4 1 3.7 1 t = − 0.96 (68) 0.340
 GAF 48.8 10.1 49.9 10.8 47.6 9.4 z = 1.170 0.242
 CAN unmet needs 4.1 2.98 3.6 2.97 4.7 2.94 z = − 1.705 0.088
 EUROQUEL VAS 8.4 20.7 84 21.2 84.8 20.4 z = − 0.200 0.842
 MARS 5.9 1.88 5.8 1.87 6.0 1.93 t = − 0.36 (71) 0.723
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Brief psychoeducation has reduced relapse in the 
medium term and promoted medication adherence in 
the short term [31]. Improved clinical outcomes have 
included reduced relapse and improvement in treat-
ment adherence [32]. Many of our participants reported 
inadequate and inconsistent current psychoeducation 
approaches within routine MHSU discharge processes, 
potentially alluding to inadequate discharge planning. 
Good discharge planning may be affected by the qual-
ity of the therapeutic alliance, which in turn is often 
impacted by the clinician’s clinical experience [33–36].
While text messaging is a promising and acceptable 
tool to aid medication and clinic adherence in mental 
illness, the evidence base remains inconclusive [14, 37, 
38]. Our formative work found support for text message 
prompts [17]. Some challenges encountered during the 
trial however, included participant factors such as chang-
ing numbers and loss of handsets, impacting negatively 
on the utility of text messaging, as did fieldworker factors 
including software challenges and loss of handsets. Soci-
oeconomic factors and the complexity of the software 
thus impacted negatively on the utility of text message 
prompts in our setting.
In conclusion, a treatment-partner psychoeducation 
intervention is acceptable and feasible in a LMIC set-
ting. Psychoeducation must be tailored to the needs of 
Table 3 Efficacy outcomes
a Log-Poisson regression model with robust variance estimation, ITT; adjusted for age, sex, substance use disorder, baseline scores of PANSS total score, GAF score, 
MARS, EUROQUEL VAS scale, CAN unmet needs score
b Log-Poisson regression model with robust variance estimation, ITT; sex dropped from model, adjusted for adjusted for age, substance use disorder, baseline scores 
of PANSS total score, GAF score, MARS, EUROQUEL VAS scale, CAN unmet needs score. Baseline data were imputed
c Multiple linear regression models adjusted for age, sex, substance use disorders, baseline scores of PANSS total score, GAF, EUROQUEL, MARS, CAN unmet needs. 
Models with violation of linear regression assumptions omitted
d Sample size varied due to list-wise deletion
e Only models for which missing data < 55% are reported





Intention‑to‑treat analysis (ITT): non‑adherence to first clinic visit, re‑admission over 9 months
 Non‑adherence to first clinic appointment
  Intervention (n = 42) 14 33.3 0.72 0.79 0.419 0.44 to 1.39
  Treatment as usual (n = 35) 16 45.7 – – – –
 Any re‑admission over 9 months
  Intervention (n = 42) 5 11.9 0.83 0.86 0.713 0.39 to 1.87
  Treatment as usual (n = 35) 5 14.3 – – – –
Outcome Complete case  analysisc (intervention vs. TAU) ITT (intervention vs. TAU)
Mean  differenced p value 95% CI Mean  differencee (n = 77) p value 95% CI
Unadjusted Adjusted Unadjusted Adjusted
Complete case and intention to treat analysis (ITT) of other efficacy outcomes at 3 months
 PANSS score
  Total score − 9.4 − 14.7 0.052 − 29.71 to 0.16 − 13.4 − 13.1 0.062 − 27.00 to 0.73
  Positive subscale − 3.8 − 6.4 0.011 − 11.20 to 1.60 − 5.6 − 5.4 0.060 − 11.16 to 0.25
  Negative subscale − 2.6 −4.4 0.059 − 8.99 to 0.18 − 3.5 − 3.5 0.078 − 7.52 to 0.43
  General subscale − 2.8 − 3.9 0.350 − 12.6 1 to 4.68 − 4.4 − 4.2 0.248 − 11.67 to 3.19
 MARS − 0.21 − 0.75 0.425 − 2.68 to 1.17 0.36 0.49 0.603 − 1.44 to 2.43
 CGI − 0.8 − 0.58 0.346 − 1.84 to 0.67 – – – –
 GAF 7.5 4.1 0.440 − 6.90 to 15.17 – – – –
 CAN – – – –
  Total needs – – – – – – – –
  Unmet needs − 3.2 − 3.6 0.029 − 6.74 to 0.49 – – – –
  Met needs – – – – – – – –
EUROQUEL‑VAS 16.1 15.2 0.124 − 4.59 to 34.99 – – – –
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the specific population targeted, and take into account 
the need for ongoing reinforcement. M-health may 
have potential to improve adherence, but text message 
prompts may be problematic in some LMIC settings such 
as ours at present. Such additional components of such 
interventions must be tailored to the local context. The 
assessment of efficacy for such an intervention requires 
appropriately powered studies.
Limitations
  • Sample size was insufficiently powered for the effi-
cacy analyses. Our primary focus of was on accept-
ability and feasibility. The work done here allows 
a power analysis for future efficacy research using 
larger samples.
  • The mental health nurses experienced challenges 
interacting with the text message system. This com-
promised appointment checking and rescheduling.
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